Functional expression of sinusoidal drug transporters in primary human and rat hepatocytes

被引:92
作者
Jigorel, E
Le Vee, M
Boursier-Neyret, C
Bertrand, M
Fardel, O
机构
[1] Fac Pharm, INSERM, U620, F-35043 Rennes, France
[2] Technol Serv, Orleans, France
关键词
D O I
10.1124/dmd.105.004762
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Primary hepatocyte cultures are considered as a useful in vitro system for pharmacological/ toxicological studies. Although expression of drug-metabolizing enzymes and canalicular drug transporters has been well documented in this cellular model, less information is available about sinusoidal drug transporter activities. This has led us to investigate functional expression of the major sinusoidal transporters in primary human and rat hepatocytes. Using radiolabeled substrates and chemical transporter inhibitors, activities of organic cation transporter 1, organic anion-transporting polypeptides, organic anion transporter 2, and Na+-taurocholate cotransporter were detected in cultured human and rat hepatocytes. In parallel, mRNA expression of these transporters was demonstrated using reverse transcriptase-quantitative polymerase chain reaction assays. Functional expression of sinusoidal transport proteins markedly decreased with time in primary rat hepatocyte cultures; by contrast, it remained relatively constant in primary human hepatocytes all along the culture, illustrating the fact that liver-specific functions, including drug-detoxifying pathways, are usually better preserved in cultured human hepatocytes than in their rodent counterparts. Primary hepatocytes, especially human hepatocytes, thus exhibit a pattern of sinusoidal transporter expression close to that found in vivo, highlighting the interest of hepatocyte cultures for drug detoxification studies.
引用
收藏
页码:1418 / 1422
页数:5
相关论文
共 26 条
[1]   Assessment of drug interactions in hepatobiliary transport using rhodamine 123 in sandwich-cultured rat hepatocytes [J].
Annaert, PP ;
Brouwer, KLR .
DRUG METABOLISM AND DISPOSITION, 2005, 33 (03) :388-394
[2]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[3]   The complexities of hepatic drug transport: Current knowledge and emerging concepts [J].
Chandra, P ;
Brouwer, KLR .
PHARMACEUTICAL RESEARCH, 2004, 21 (05) :719-735
[4]   Drug transport proteins in the liver [J].
Faber, KN ;
Müller, M ;
Jansen, PLM .
ADVANCED DRUG DELIVERY REVIEWS, 2003, 55 (01) :107-124
[5]   OVEREXPRESSION OF THE MULTIDRUG RESISTANCE GENE-PRODUCT IN ADULT-RAT HEPATOCYTES DURING PRIMARY CULTURE [J].
FARDEL, O ;
RATANASAVANH, D ;
LOYER, P ;
KETTERER, B ;
GUILLOUZO, A .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1992, 205 (02) :847-852
[6]   P-GLYCOPROTEIN EXPRESSION IN HUMAN, MOUSE, HAMSTER AND RAT HEPATOCYTES IN PRIMARY CULTURE [J].
FARDEL, O ;
MOREL, F ;
GUILLOUZO, A .
CARCINOGENESIS, 1993, 14 (04) :781-783
[7]  
Gao B, 2000, J PHARMACOL EXP THER, V294, P73
[8]   New hepatocyte in vitro systems for drug metabolism:: Metabolic capacity and recommendations for application in basic research and drug development, standard operation procedures [J].
Gebhardt, R ;
Hengstler, JG ;
Müller, D ;
Glöckner, R ;
Buenning, P ;
Laube, B ;
Schmelzer, E ;
Ullrich, M ;
Utesch, D ;
Hewitt, N ;
Ringel, M ;
Hilz, BR ;
Bader, A ;
Langsch, A ;
Koose, T ;
Burger, HJ ;
Maas, J ;
Oesch, F .
DRUG METABOLISM REVIEWS, 2003, 35 (2-3) :145-213
[9]   Human hepatocytes as a tool for studying toxicity and drug metabolism [J].
Gómez-Lechón, MJ ;
Donato, MT ;
Castell, JV ;
Jover, R .
CURRENT DRUG METABOLISM, 2003, 4 (04) :292-312
[10]   USE OF HUMAN HEPATOCYTE CULTURES FOR DRUG-METABOLISM STUDIES [J].
GUILLOUZO, A ;
MOREL, F ;
FARDEL, O ;
MEUNIER, B .
TOXICOLOGY, 1993, 82 (1-3) :209-219